Epidemiology and determinants of chronic migraine: A real-world cohort study, with nested case-control analysis, in primary care in Italy

被引:5
|
作者
Marconi, Ettore [1 ]
Pecchioli, Serena [1 ]
Nica, Mihaela [2 ]
Colombo, Delia [2 ]
Mazzoleni, Francesco [3 ]
De Cesaris, Francesco [4 ]
Geppetti, Pierangelo [4 ]
Cricelli, Claudio [3 ]
Lapi, Francesco [1 ]
机构
[1] Italian Coll Gen Practitioners & Primary Care, Hlth Search, Via Sansovino 179, I-50142 Florence, Italy
[2] Novartis Farma SpA, Patient Access, Origgio, VA, Italy
[3] Italian Coll Gen Practitioners & Primary Care, Florence, Italy
[4] Azienda Osped Univ Careggi, Headache Ctr, Florence, Italy
关键词
Headache; chronic migraine; primary health care; epidemiology; EPISODIC MIGRAINE; HEADACHE; POPULATION; OVERUSE; BURDEN; PREVALENCE; DISABILITY; DIAGNOSIS; ONSET; RATES;
D O I
10.1177/0333102419889351
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background The proper identification of chronic migraine is one of the mainstays for general practitioners. This study therefore aims to assess the epidemiology and determinants of chronic migraine in primary care in Italy by testing five operational case definition algorithms. Methods Five case definition algorithms defining chronic migraine were developed to estimate the prevalence and incidence rate of chronic migraine in the Health Search database. For each algorithm, we conducted a nested case-control analysis to quantify the level of association between certain determinants and incident cases of chronic migraine. Results Considering a cohort of 1,091,032 patients (52% were females), the prevalence rate of chronic migraine increased from the first to the fifth case definition algorithm ranging from 0.03 to 0.28%. No 95% confidence interval overlapped the others, and every confidence interval reliably maintained 2% precision. Incidence rates showed a growing trend (0.008-0.056 per 100,000 person-years) as well. All case definition algorithms were able to capture sex (i.e. female) and nonsteroidal anti-inflammatory drug (NSAID) overuse as statistically significant determinants of incident cases of chronic migraine. Depression was associated with a statistically significant increase of incidence rate of chronic migraine only for two case definition algorithms. Conclusion Our findings show that prevalence and incidence rate of chronic migraine are underestimated when compared with current literature. On the other hand, we found acceptable correctness of chronic migraine definition in the light of the association with well-known determinants.
引用
收藏
页码:461 / 469
页数:9
相关论文
共 50 条
  • [21] Chronic Viral Hepatitis in a Cohort of Inflammatory Bowel Disease Patients from Southern Italy: A Case-Control Study
    Losurdo, Giuseppe
    Iannone, Andrea
    Contaldo, Antonella
    Barone, Michele
    Ierardi, Enzo
    Di Leo, Alfredo
    Principi, Mariabeatrice
    PATHOGENS, 2020, 9 (11): : 1 - 10
  • [22] A prospective real-world analysis of erenumab in refractory chronic migraine
    Giorgio Lambru
    Bethany Hill
    Madeleine Murphy
    Ivona Tylova
    Anna P. Andreou
    The Journal of Headache and Pain, 2020, 21
  • [23] Prospective real-world analysis of OnabotulinumtoxinA in chronic migraine post-National Institute for Health and Care Excellence UK technology appraisal
    Andreou, A. P.
    Trimboli, M.
    Al-Kaisy, A.
    Murphy, M.
    Palmisani, S.
    Fenech, C.
    Smith, T.
    Lambru, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2018, 25 (08) : 1069 - +
  • [24] A single-center retrospective study of onabotulinumtoxinA for treatment of 245 chronic migraine patients: survey results of a real-world experience
    Dikmen, Pinar Yalinay
    Kosak, Seda
    Aydinlar, Elif Ilgaz
    Kocaman, Ayse Sagduyu
    ACTA NEUROLOGICA BELGICA, 2018, 118 (03) : 475 - 484
  • [25] The Rorschach Test Evaluation in Chronic Childhood Migraine: A Preliminary Multicenter Case-Control Study
    Esposito, Maria
    Messina, Antonietta
    Monda, Vincenzo
    Bitetti, Ilaria
    Salerno, Filomena
    Precenzano, Francesco
    Pisano, Simone
    Salvati, Tiziana
    Gritti, Antonella
    Marotta, Rosa
    Lavano, Serena Marianna
    Lavano, Francesco
    Maltese, Agata
    Parisi, Lucia
    Salerno, Margherita
    Tripi, Gabriele
    Gallai, Beatrice
    Roccella, Michele
    Bove, Domenico
    Ruberto, Maria
    Toraldo, Roberto
    Messina, Giovanni
    Carotenuto, Marco
    FRONTIERS IN NEUROLOGY, 2017, 8
  • [26] Real-World Evidence for Control of Chronic Migraine Patients Receiving CGRP Monoclonal Antibody Therapy Added to OnabotulinumtoxinA: A Retrospective Chart Review
    Blumenfeld, Andrew M.
    Frishberg, Benjamin M.
    Schim, Jack D.
    Iannone, Ashley
    Schneider, Gary
    Yedigarova, Larisa
    Manack Adams, Aubrey
    PAIN AND THERAPY, 2021, 10 (02) : 809 - 826
  • [27] Real-world effectiveness of onabotulinumtoxinA treatment for the prevention of headaches in adults with chronic migraine in Australia: a retrospective study
    Catherine Stark
    Richard Stark
    Nicole Limberg
    Julian Rodrigues
    Dennis Cordato
    Raymond Schwartz
    Robert Jukic
    The Journal of Headache and Pain, 2019, 20
  • [28] Adherence With Bisphosphonates and Long-Term Risk of Hip Fractures: A Nested Case-Control Study Using Real-World Data
    Shalev, Varda
    Moser, Sarah Sharman
    Goldshtein, Inbal
    Yu, Jingbo
    Weil, Clara
    Ish-Shalom, Sophia
    Rouach, Vanessa
    Chodick, Gabriel
    ANNALS OF PHARMACOTHERAPY, 2017, 51 (09) : 757 - 767
  • [29] PEARL study protocol: a real-world study of fremanezumab effectiveness in patients with chronic or episodic migraine
    Ashina, Messoud
    Amin, Faisal Mohammad
    Kokturk, Pinar
    Cohen, Joshua M.
    Konings, Martijn
    Tassorelli, Cristina
    Lyras, Leonidas
    Mitsikostas, Dimos-Dimitrios
    PAIN MANAGEMENT, 2021, 11 (06) : 647 - 654
  • [30] Protocol for a nested case-control study design for omics investigations in the Environmental Determinants of Islet Autoimmunity cohort
    Oakey, Helena C.
    Giles, Lynne L.
    Thomson, Rebecca
    Le Cao, Kim-Anh
    Ashwood, Pat D.
    Brown, James J.
    Knight, Emma C.
    Barry, Simon E.
    Craig, Maria G.
    Colman, Peter A.
    Davis, Elizabeth E.
    Hamilton-Williams, Emma C.
    Harrison, Leonard
    Haynes, Aveni
    Kim, Ki Wook
    Mallitt, Kylie-Ann
    McGorm, Kelly
    Morahan, Grant D.
    Rawlinson, William O.
    Sinnott, Richard
    Soldatos, Georgia M.
    Wentworth, John J.
    Couper, Jennifer
    Penno, Megan A. S.
    ENDIA Study Grp
    ANNALS OF MEDICINE, 2023, 55 (01)